The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Legro, R. S., Finegood, D., & Dunaif, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5054 · Cited by 673
Carmina, E., & Lobo, R. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5803 · Cited by 528
Self-citation
Cited by
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“Some studies have attempted to determine the cutoff values for HOMA or QUICKI, which may be useful in epidemiologic studies or in clinical practice (184, 196).”
BackgroundSelf-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationPolycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“With PCOS and obesity together causing the greatest impairment of insulin sensitivity, insulin resistance occurs in approximately 50–70% of women with PCOS and in 95% of obese women with PCOS”
BackgroundEpidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Self-citationUnderstanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686
DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589
Rojas, J., Chávez, M., Olivar, L., Rojas, M., Morillo, J., Mejías, J., Calvo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 467
Metformin: a review of its potential indications
Wang, Y.-W., He, S.-J., Feng, X., Cheng, J., Luo, Y.-T., Tian, L., & Huang, Q. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s141675 · Cited by 320
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317
“In PCOS patients, the stronger correlations were between serum insulin and R1 fat (r 0.65, P 0.01) and between R1 fat and QUICKI (r 0.73, P 0.001).”
MethodInfluentialSelf-citationCarmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2279 · Cited by 274
Self-citationExercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242
“Metabolic disturbance is not uncommon in women affected by PCOS, with a prevalence of insulin resistance ranging from 50% to 70% [77–79], and up to 70% for dyslipidemia [10].”
BackgroundDaan, N. M. P., Louwers, Y. V., Koster, M. P. H., Eijkemans, M. J. C., de Rijke, Y. B., Lentjes, E. W. G., Fauser, B. C. J. M., & Laven, J. S. E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.08.001 · Cited by 217
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
Chu, M. C., Cosper, P., Orio, F., Carmina, E., & Lobo, R. A. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.06.073 · Cited by 113
Self-citationPuurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108
Wen, Q., Hu, M., Lai, M., Li, J., Hu, Z., Quan, K., Liu, J., Liu, H., Meng, Y., Wang, S., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deab272 · Cited by 93
Harrison, C. L., Stepto, N. K., Hutchison, S. K., & Teede, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04160.x · Cited by 80
Georgopoulos, N. A., Saltamavros, A. D., Vervita, V., Karkoulias, K., Adonakis, G., Decavalas, G., Kourounis, G., Markou, K. B., & Kyriazopoulou, V. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.067 · Cited by 80
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2336 · Cited by 66
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Barr, S., Reeves, S., Sharp, K., & Jeanes, Y. M. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.06.347 · Cited by 54
Patel, R., & Shah, G. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1279597 · Cited by 47
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Chen, T., Yu, Y., Jia, F., Luan, P., & Liu, X. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.960965 · Cited by 37
Penaforte, F. R. O., Japur, C. C., Diez-Garcia, R. W., & Chiarello, P. G. (2011) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2010.01130.x · Cited by 35
Soares, N. P., Santos, A. C. S. D., Costa, E. C., Azevedo, G. D., Damasceno, D. C., Fayh, A. P. T., & Lemos, T. M. A. M. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000444130 · Cited by 31
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS
Li, X., Yang, D., Pan, P., Azziz, R., Yang, D., Cheng, Y., & Zhao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873726 · Cited by 18
Kim, N., & Chun, S. (2021) · Clinical and Experimental Reproductive Medicine · doi:10.5653/cerm.2021.04553 · Cited by 10
“Common metabolic problems associated with PCOS are glucose intolerance, type 2 diabetes mellitus (T2DM), central obesity, insulin resistance, and hyperinsulinemia [1-6].”
BackgroundInfluentialInsulin, ghrelin and early return of hunger in women with obesity and polycystic ovary syndrome
Japur, C. C., Diez-Garcia, R. W., de Oliveira Penaforte, F. R., das Graças Pena, G., de Araújo, L. B., & de Sá, M. F. S. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.013 · Cited by 8
Evaluation of potential association of metabolic syndrome in obese and non-obese PCOS women
Kaur, R., & Kaur, M. (2024) · Middle East Fertility Society Journal · doi:10.1186/s43043-024-00170-0 · Cited by 2
“Past literature [3, 37, 38] also highlighted a strong association between obesity and metabolic syndrome.”
Background
Metadata
- Authors
- Carmina, E., & Lobo, R. A.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 82
- Issue
- 3
- Pages
- 661-665
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2099619883
- Cited by
- 294
- References
- 24
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.